Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/3716272

Beta release

Statistics of Efficacy and safety of lenabasum, a cannabinoid type 2 receptor agonist, in a phase 3 randomized trial in diffuse cutaneous systemic sclerosis
Statistics for this year
PeriodVisitsDownloads
20243128
Statistics for the last 3 months
PeriodVisitsDownloads
2024-0922
2024-1011
2024-1100